Said Younis, Doron Rimar, Gleb Slobodin, Itzhak Rosner. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdalimumabAntibodies, Monoclonal, Humanized/adverse effectsAntibodies, Monoclonal, Humanized/therapeutic useAntirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyFemaleHumansMiddle AgedPsoriasis/chemically inducedPsoriasis/drug therapyReceptors, Interleukin-6/antagonists & inhibitorsTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Antibodies, Monoclonal, HumanizedAntirheumatic AgentsReceptors, Interleukin-6Tumor Necrosis Factor-alphaAdalimumabtocilizumab
Year: 2012 PMID： 23028035 DOI： 10.3899/jrheum.120304
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666